Dr. Motanya was born and raised in Indiana always knowing she would one day serve her community in the medical field. She went to the University of Pittsburgh to study sociology and chemistry. She then moved to Philadelphia to attend University of Pennsylvania for Pre-Health Specialized Studies and eventually, Temple University School of Podiatric Medicine. Dr. Motanya trained at Jefferson Health New Jersey, a high-volume surgical residency program in South Jersey, where she solidified her core values of clear communication, surgical excellence, and dedication to growth. While Dr. Motanya takes pride in her ability to confidently treat many different foot and ankle pathologies, she also completed a Wound Care Fellowship at St. John’s Episcopal Hospital for more exposure to skin-related manifestations of complex illness.
After some years in private practice, Dr. Motanya understands that biomechanics and early intervention are crucial tools to the podiatric physician if treatment, not symptom management, is the goal. For this reason, Dr. Motanya has embraced a shift to prioritize pediatric evaluation and neutralizing abnormal biomechanical forces in patients of all ages. Her practice involves both surgical and conservative measures to ensure that patients are safely back on their feet in a timely fashion.
On weekends, Dr. Motanya finds any excuse to be outdoors in nature, whether it is running, hiking or yoga. She also enjoys spending time with her family in Brooklyn, attending educational lectures around the city and trying new restaurants. She is excited about making New York City her home with her energetic Mastiff.
Education
- BS, University of Pittsburgh
- DPM, Temple School of Podiatric Medicine
Certifications
- Diplomate, American Board of Podiatric Medicine
Research
Dr. Motanya’s research interests include foot type and pathology by race, casting methods for custom foot orthoses, and relationship between radiographic findings and orthotic use.
Publications
- Murciano-Goroff YR, McCarthy AM, Bristol MN, et. al. "Medical oncologists' willingness to participate in bundled payment programs." BMC health services research, 18(1), (2018) 391. doi: 10.1186/s12913-018-3202-y
- Murciano-Goroff YR, McCarthy AM, Bristol MN, et. al. "Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists." Breast cancer research and treatment, 171(1), (2018) 173-180. doi: 10.1007/s10549-018-4810-2
- McCarthy AM, Bristol M, Domchek SM, et. al. "Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34(22), (2016) 2610-8. doi: 10.1200/JCO.2015.66.0019
- Goldsack JC, Reilly C, Bush C, et. al. "Impact of shortages of injectable oncology drugs on patient care." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 71(7), (2014) 571-8. doi: 10.2146/ajhp130569
- Schopfer FJ, Cole MP, Groeger AL, et. al. "Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions." The Journal of biological chemistry, 285(16), (2010) 12321-33. doi: 10.1074/jbc.M109.091512
- Cole MP, Rudolph TK, Khoo NK, et. al. "Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury." Circulation research, 105(10), (2009) 965-72. doi: 10.1161/CIRCRESAHA.109.199075
Memberships and Affiliations
- American Podiatric Medical Association
Hobbies
- Running
- Hiking
- Yoga
